Please provide your email address to receive an email when new articles are posted on . Time in range was similar with a fully closed-loop system delivering insulin lispro and pramlintide compared ...

Please provide your email address to receive an email when new articles are posted on . In reporting findings from the phase 2b Insulin Liver Effect (ISLE-1) trial, the researchers also found that ...

The standard treatment for patients with diabetic ketoacidosis (DKA) is the use of low-dosage intravenous, subcutaneous, or intramuscular insulin. Although all routes of administration have been shown ...

This week, the FDA approved LYUMJEV (insulin lispro-aabc), a new insulin lispro product by Lilly. LYUMJEV is a formulation of insulin lispro, developed to speed the absorption of insulin into the ...

CLEVELAND, May 26, 2026 (GLOBE NEWSWIRE) -- Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing portal-hepatic targeted therapies for metabolic disease, today ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for insulin lispro 100 Units/mL (Insulin lispro Sanofi). The product is a ...

Eli Lilly is continuing to work to lower the out-of-pocket costs for people using insulin. The company announced that it is lowering the list price of Insulin Lispro Injection by an additional 40% ...

INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's ...

The cost of insulin has been a major policy issue in recent years. FDA Commissioner Scott Gottlieb, MD, said the approval of a new choice in insulin was a sign of his commitment to giving patients ...

Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Recombinant Lispro Insulin Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering. By the end of ...

In recent years, insulin makers Eli Lilly, Sanofi and Novo Nordisk have bowed to pressure to reduce prices. (Getty/Samara Heisz) () With drugmakers facing renewed calls to lower the cost of ...

Pakistan’s health ministry says Apidra insulin is unavailable due to global supply issues but alternatives exist.